DFTX Definium Therapeutics, Inc.
Definium Therapeutics, Inc. (DFTX) Institutional Ownership
What the institutions did with DFTX last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended September 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeOwnership map
Each block is one manager, sized by shares held and colored by how much they moved the position last quarter. Green added, red cut, grey stood pat.
Largest holders
| Manager | Shares | % of reported |
|---|---|---|
| BlackRock, Inc. | 11.8M | 18.2% |
| FMR LLC | 9.1M | 14.1% |
| Avoro Capital Advisors LLC | 7.1M | 10.9% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.4M | 6.8% |
| WELLINGTON MANAGEMENT GROUP LLP | 3.7M | 5.7% |
| GEODE CAPITAL MANAGEMENT, LLC | 3.6M | 5.6% |
| STATE STREET CORP | 3.3M | 5.1% |
| Capital International Investors | 3.0M | 4.6% |
| NORTHERN TRUST CORP | 1.2M | 1.8% |
| Woodline Partners LP | 1.0M | 1.6% |
| LORD, ABBETT & CO. LLC | 958.6K | 1.5% |
| UBS Group AG | 928.7K | 1.4% |
| Bank of New York Mellon Corp | 850.3K | 1.3% |
| Polar Capital Holdings Plc | 776.0K | 1.2% |
| BARCLAYS PLC | 761.9K | 1.2% |
| Nuveen, LLC | 685.5K | 1.1% |
| FRANKLIN TEMPLETON INC | 580.4K | 0.9% |
| Balyasny Asset Management L.P. | 549.4K | 0.9% |
| Candriam S.C.A. | 515.3K | 0.8% |
| MARSHALL WACE, LLP | 491.0K | 0.8% |
| ArrowMark Colorado Holdings LLC | 469.8K | 0.7% |
| ASSETMARK, INC | 400.0K | 0.6% |
| Patient Square Capital LP | 385.0K | 0.6% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 367.1K | 0.6% |
| Logos Global Management LP | 350.0K | 0.5% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| FMR LLC | Increased | 4.8M | 9.1M | +4.3M |
| Siren, L.L.C. | Sold Out | 1.4M | 0 | -1.4M |
| LORD, ABBETT & CO. LLC | New | 0 | 958.6K | +958.6K |
| MARSHALL WACE, LLP | Reduced | 1.3M | 491.0K | -807.9K |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 2.9M | 3.7M | +722.2K |
| BARCLAYS PLC | Increased | 50.3K | 761.9K | +711.6K |
| BlackRock, Inc. | Increased | 11.2M | 11.8M | +539.8K |
| UBS Group AG | Increased | 499.5K | 928.7K | +429.2K |
| Nuveen, LLC | Reduced | 1.1M | 685.5K | -419.8K |
| Patient Square Capital LP | New | 0 | 385.0K | +385.0K |
| Balyasny Asset Management L.P. | Reduced | 897.7K | 549.4K | -348.2K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 41.0K | 367.1K | +326.2K |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 4.7M | 4.4M | -285.8K |
| Logos Global Management LP | Increased | 80.0K | 350.0K | +270.0K |
| Squadron Capital Management LLC | Increased | 85.0K | 340.0K | +255.0K |
| STATE STREET CORP | Increased | 3.1M | 3.3M | +235.7K |
| Trexquant Investment LP | Sold Out | 233.2K | 0 | -233.2K |
| MILLENNIUM MANAGEMENT LLC | Reduced | 266.1K | 40.5K | -225.6K |
| Eversept Partners, LP | Sold Out | 217.2K | 0 | -217.2K |
| EMERALD ADVISERS, LLC | Sold Out | 178.8K | 0 | -178.8K |
| Russell Investments Group, Ltd. | Increased | 153.5K | 331.7K | +178.2K |
| Clearbridge Investments, LLC | New | 0 | 148.8K | +148.8K |
| Avoro Capital Advisors LLC | Reduced | 7.2M | 7.1M | -138.9K |
| HighVista Strategies LLC | Reduced | 242.9K | 109.1K | -133.8K |
| VAN ECK ASSOCIATES CORP | New | 0 | 132.3K | +132.3K |
| Cormorant Asset Management, LP | Reduced | 400.0K | 275.0K | -125.0K |
| Atika Capital Management LLC | Sold Out | 122.0K | 0 | -122.0K |
| EMERALD MUTUAL FUND ADVISERS TRUST | Sold Out | 121.2K | 0 | -121.2K |
| Candriam S.C.A. | Reduced | 614.4K | 515.3K | -99.1K |
| Moody Aldrich Partners LLC | Increased | 51.0K | 148.9K | +97.8K |
| ArrowMark Colorado Holdings LLC | Reduced | 564.1K | 469.8K | -94.2K |
| FRANKLIN TEMPLETON INC | Increased | 486.2K | 580.4K | +94.1K |
| TD ASSET MANAGEMENT INC | Reduced | 209.5K | 118.1K | -91.4K |
| PFM Health Sciences, LP | Increased | 249.0K | 335.1K | +86.1K |
| FEDERATED HERMES, INC. | New | 0 | 83.8K | +83.8K |
| Atom Investors LP | Increased | 49.4K | 125.8K | +76.4K |
| Bank of New York Mellon Corp | Increased | 777.3K | 850.3K | +73.0K |
| VOYA INVESTMENT MANAGEMENT LLC | Increased | 95.2K | 166.4K | +71.3K |
| JPMORGAN CHASE & CO | Increased | 266.0K | 337.2K | +71.2K |
| XTX Topco Ltd | Reduced | 84.4K | 13.8K | -70.6K |
| Lisanti Capital Growth, LLC | New | 0 | 69.6K | +69.6K |
| Rockefeller Capital Management L.P. | Reduced | 70.1K | 1.2K | -68.9K |
| ALPS ADVISORS INC | Increased | 110.4K | 178.0K | +67.6K |
| CASTLEARK MANAGEMENT LLC | New | 0 | 67.2K | +67.2K |
| Premier Fund Managers Ltd | New | 0 | 61.4K | +61.4K |
| BNP PARIBAS FINANCIAL MARKETS | Reduced | 96.5K | 37.8K | -58.7K |
| NOMURA HOLDINGS INC | New | 0 | 58.6K | +58.6K |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | New | 0 | 48.0K | +48.0K |
| SEI INVESTMENTS CO | Increased | 28.6K | 74.1K | +45.5K |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | Reduced | 146.4K | 104.0K | -42.3K |
| ROYCE & ASSOCIATES LP | Increased | 208.6K | 250.5K | +42.0K |
| AdvisorShares Investments LLC | Increased | 121.4K | 161.6K | +40.2K |
| Connor, Clark & Lunn Investment Management Ltd. | Increased | 8.3K | 47.4K | +39.1K |
| Caption Management, LLC | Reduced | 45.0K | 6.2K | -38.8K |
| Y-Intercept (Hong Kong) Ltd | Reduced | 54.5K | 16.0K | -38.5K |
| Bellevue Group AG | Increased | 8.4K | 46.5K | +38.1K |
| Legato Capital Management LLC | New | 0 | 36.0K | +36.0K |
| CenterBook Partners LP | Reduced | 41.3K | 9.1K | -32.2K |
| Birchview Capital, LP | Increased | 20.0K | 52.0K | +32.0K |
| Waterloo Capital, L.P. | New | 0 | 31.3K | +31.3K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.